The Worldwide Immuno-Oncology Assays Industry is Projected to Reach $7.9 Billion by 2026 at a CAGR of 12.5% from 2021
Share this article Share this article ResearchAndMarkets.com's offering. The global immuno-oncology assays market is projected to reach USD 7.9 billion by 2026 from USD 4.4 billion in 2021, at a CAGR of 12.5% during the forecast period. Market growth is driven by factors such as the growing significance of companion diagnostics in drug development and rising incidence of cancer and growing adoption of targeted therapies. On the other hand, the requirement of high capital investments and low cost-benefit ratio and the unfavorable regulatory and reimbursement scenario are the major factors hamp...